http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104961687-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37823ed18fa795f88a104ed9913a21d2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
filingDate 2015-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2071eb393e2fce40842631e2c6a273c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_757bcab09f337038db79aa8646bb0f19
publicationDate 2015-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104961687-A
titleOfInvention 1,2-diazine derivatives and their preparations and uses
abstract The present invention relates to 1,2-diazine derivatives and their preparations and uses. The 1,2-diazine derivatives have the chemical structural formula shown in general formula I: ; Wherein, R 1 represents a substituent, which is H, C 1 -C 4 saturated alkyl, C 3 -C 6 cycloalkyl, C 6 -C 10 aromatic ring or C 3 -C 7 aromatic heterocyclic ring; X is OH , COOH, CONR 2 R 3 or CONHOH; R 2 and R 3 are H, C 1 -C 4 saturated alkyl or C 6 -C 10 aromatic ring; n is an integer 1, 2, 3, 4, 5, 6 or 7. The invention can effectively orally administer the biologically active substances to organisms, and improves the stability of the biologically active medicines in the gastrointestinal tract. More importantly, the content of the active substance entering the living body has at least the amount required to produce biological effects; the present invention solves the problem of oral administration of biomacromolecular drugs, and also provides patients with a convenient way to treat diseases.
priorityDate 2015-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101621991-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010111271-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103458873-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5503852-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0245754-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012189666-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468248031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468275688

Total number of triples: 36.